These findings suggest that increased tumor grading (captured by Ki‐67) is associated also with impairment of anti‐tumor immunity through HLA‐I downmodulation, reduced CD8 infiltration and enhanced PD‐L1 expression on tumor cells. Here, MKI67 is linked to neoplasm.